Targeting-Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy

Photodynamic therapy (PDT) and photothermal therapy (PTT) possess advantages over the conventional therapies with additional treatment selectivity achieved with local laser irradiation. Comparing to PTT that ablates target tissue via thermal necrosis, PDT induces target cell death via singlet oxygen...

Full description

Saved in:
Bibliographic Details
Published inAdvanced healthcare materials Vol. 3; no. 8; pp. 1240 - 1249
Main Authors Jin, Cheng S., Cui, Liyang, Wang, Fan, Chen, Juan, Zheng, Gang
Format Journal Article
LanguageEnglish
Published Germany Blackwell Publishing Ltd 01.08.2014
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Photodynamic therapy (PDT) and photothermal therapy (PTT) possess advantages over the conventional therapies with additional treatment selectivity achieved with local laser irradiation. Comparing to PTT that ablates target tissue via thermal necrosis, PDT induces target cell death via singlet oxygen without damaging the underling connective tissue, thus preserving its biological function. Activatable photosensitizers provide an additional level of treatment selectivity via the disease‐associated activation mechanism. In this study, folate‐conjugated porphysomes are introduced as targeting‐triggered activatable nano‐sized beacons for PDT. Porphysomes are reported previously as the most stable and efficient delivery system of porphyrin, but their nanostructure converts the singlet oxygen generation mechanism to thermal ablation mechanism. By folate‐receptor‐mediated endocytosis, folate‐porphysomes are internalized into cells rapidly and resulted in efficient disruption of nanostructures, thus switching back on the photodynamic activity of the densely packed porphyrins for effective PDT. In both in vitro and in vivo studies, folate‐porphysomes can achieve folate receptor‐selective PDT efficacy, which proves the robustness of targeting‐triggered PDT activation of porphysome nanostructure for highly selective tumor ablation. The formulation of porphysomes can be modified with other targeting ligands as activatable photosensitizers for personalized treatment in future. Activatable nano‐sized beacons for photo­dynamic therapy (PDT): Intact porphysome nanoparticles are inactive for PDT. By incorporating targeting ligands (e.g., folate) into porphysome formulation, receptor‐mediated endocytosis facilitates the disruption of the nanostructure inside cells, thus switching back on the photo­dynamic activity of the densely packed porphyrins for effective PDT.
Bibliography:Natural Sciences and Engineering Research Council of Canada
Canadian Foundation for Innovation
Joey and Toby Tanenbaum/Brazilian Ball Chair in Prostate Cancer Research
Canadian Institute of Health Research
Canadian Space Agency
Princess Margaret Cancer Center Foundation
ArticleID:ADHM201300651
Prostate Cancer foundation of Canada
MaRS Innovation
US Army - No. W81XWH-13-1-0442
istex:FF25C487517183CC7C08E4306562434AFAD9D4F9
ark:/67375/WNG-V6KMDPND-K
Canadian Cancer Society Research Institute
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:2192-2640
2192-2659
2192-2659
DOI:10.1002/adhm.201300651